A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Korea

Study Overview
=================
Brief Summary
-----------------
This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control, and complications in diabetic subjects in Asia.

Official Title
-----------------
DiabCare Asia 2008 (Korea): A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia & To Evaluate Perceptions and Practices of Physicians & Patients About Diabetes Management in Asia

Conditions
-----------------
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Intervention / Treatment
-----------------
* Other: No treatment given


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Diabetic patients registered in the particular centre for more than 12 months. Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit. Patients willing to sign informed consent form. Exclusion Criteria: Repetition of any patient as patients should not be included twice for any reason. Unwilling to participate or unable to comply with protocol requirements.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| A<br> | Other: No treatment given<br>* Subject will only fill out a questionaire when entering the observational study<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Mean age of onset of type 1 and type 2 diabetes mellitus, respectively |  | at baseline visit/study start | 
| Mean duration of treatment of type 2 diabetes mellitus. |  | at baseline visit/study start | 
| Percentage of patients on insulin and Oral Anti-Diabetics Drugs (OADs) therapy, respectively |  | at baseline visit/study start | 
| Mean duration of diabetes in type 1 and type 2 diabetic patients respectively |  | at baseline visit/study start | 
| Mean FPG (fasting plasma glucose),PPG (post prandial glucose) and HbA1c of diabetic patients. |  | at baseline visit/study start | 
| Percentage of diabetic patients with HbA1c target below 7.0% and below 6.5%, respectively |  | at baseline visit/study start | 
| Percentage of diabetic patients having dyslipidemia and hypertension, cardiovascular complications, peripheral vascular disease, diabetic nephropathy and diabetic eye complications, respectively |  | at baseline visit/study start | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patients' perception will be analysed through patient questionnaire measuring psychological well-being, quality of life and patients' compliant to treatment |  | at baseline visit/study start | 
| Physician perception of diabetes and its management will be analysed through physician questionnaire measuring awareness about: HbA1c test and its goal, anti-diabetic treatment, barriers towards optimum diabetes control |  | at baseline visit/study start | 
| Duration of diabetes associated with highest number of diabetic complications |  | at baseline visit/study start | 
| Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, nephropathy and retinopathy) |  | at baseline visit/study start |